RCAR - RenovaCare, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
4.91
-0.18 (-3.54%)
At close: 12:39PM EDT
Stock chart is not supported by your current browser
Previous Close5.09
Open5.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range4.86 - 5.05
52 Week Range2.55 - 12.82
Volume3,211
Avg. Volume80,591
Market Cap377.287M
Beta3.04
PE Ratio (TTM)N/A
EPS (TTM)-0.05
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • RenovaCare Board of Directors Elects Majority Stockholder Harmel S. Rayat as Chairman
    Business Wire2 months ago

    RenovaCare Board of Directors Elects Majority Stockholder Harmel S. Rayat as Chairman

    RenovaCare, Inc., , developer of the SkinGun™ and CellMist™ System for spraying a patient’s own skin stem cells onto burns and wounds for rapid self-healing, today announced the appointment of Mr.

  • RenovaCare Takes Action to Protect Shareholder Interests
    Business Wire3 months ago

    RenovaCare Takes Action to Protect Shareholder Interests

    RenovaCare, Inc. , developer of a breakthrough technology for spraying a patient’s own skin cells onto burns and wounds, announces that it has received video evidence showing what appears to be predatory trading practices of several FINRA member firms in its stock.

  • RenovaCare Issues Important Shareholder Update Following Patent Win and FDA News
    Business Wire3 months ago

    RenovaCare Issues Important Shareholder Update Following Patent Win and FDA News

    RenovaCare, Inc., , developer of the SkinGun™ and CellMist™ System for spraying a patient’s own skin stem cells onto burns and wounds for rapid self-healing, today announced new initiatives to expand its product pipeline and associated clinical indications beyond severe second-degree burns.

  • RenovaCare Secures Patent Victory and Continues to Bolster IP Portfolio
    Business Wire3 months ago

    RenovaCare Secures Patent Victory and Continues to Bolster IP Portfolio

    RenovaCare, Inc., , developer of the SkinGun™ and CellMist™ System for spraying a patient’s own skin stem cells onto burns and wounds for rapid self-healing, announced it has decisively won against patent challenger, Avita Medical, in a proceeding at the United States Patent Office .

  • ACCESSWIRE3 months ago

    Emerging Developments: New Research on RenovaCare Inc. and General Cannabis Corp. - A Look Ahead into 2018

    NEW YORK, NY / ACCESSWIRE / February 21 , 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of RenovaCare Inc. (OTCQB: RCAR ) and General Cannabis Corp. (OTCQB: ...

  • RenovaCare Announces Successful FDA Meeting
    Business Wire3 months ago

    RenovaCare Announces Successful FDA Meeting

    RenovaCare, Inc., , announced today positive outcomes from its pre-submission meeting with the United States Food and Drug Administration regarding the RenovaCare SkinGun™ and CellMist™ System for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing.

  • RenovaCare Issues Stern Response to Admitted Short-Seller, Streetsweeper, Affiliated with Felon Convicted of Securities Fraud
    Business Wire3 months ago

    RenovaCare Issues Stern Response to Admitted Short-Seller, Streetsweeper, Affiliated with Felon Convicted of Securities Fraud

    RenovaCare, Inc., , developer of the SkinGun™ and CellMist™ System for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today issued a strong rejection to Streetsweeper, known for spreading “short and distort” commentary on companies it targets for short selling, in this case RenovaCare.

  • RenovaCare Highlights Clinical Results From 44 Severe Burn Patients Published in Medical Journal
    Business Wire4 months ago

    RenovaCare Highlights Clinical Results From 44 Severe Burn Patients Published in Medical Journal

    RenovaCare, Inc., , today highlighted an analysis of treatment results from 44 patients treated for severe second-degree wide-area burn injuries, as published in Burns, the peer-reviewed Journal of the International Society for Burn Injuries.

  • RenovaCare 2018 Outlook and Shareholder Update from the CEO
    Business Wire4 months ago

    RenovaCare 2018 Outlook and Shareholder Update from the CEO

    RenovaCare, Inc., , developer of the SkinGun™ and CellMist™ System for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, is pleased to provide its outlook for 2018, which includes a shareholder update on the Company’s plans to advance its products towards market.

  • Business Wire4 months ago

    RenovaCare Comments on Recent Market Activity

    RenovaCare, Inc. , developer of the SkinGun™ and CellMist™ System for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced that on January 3rd, 2018, OTC Markets Group Inc.

  • RenovaCare SkinGun™ Stem Cell Sprayer on Exhibit at the Science Museum in London
    Business Wire7 months ago

    RenovaCare SkinGun™ Stem Cell Sprayer on Exhibit at the Science Museum in London

    RenovaCare, Inc. , developer of the SkinGun™ and CellMist™ System for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced the first-ever public display of its breakthrough technology, on exhibit now at the UK’s prestigious Science Museum in London.

  • Business Wire7 months ago

    RenovaCare Announces Successful Closing of Financing

    RenovaCare, Inc., , developer of the SkinGun™ and CellMist™ System for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced the closing of its previously announced registered direct offering of 915,000 shares of its common stock at a an offering price of $2.50 per share and its concurrent private placement of common stock purchase warrants ...

  • Business Wire7 months ago

    RenovaCare, Inc. Closes Registered Direct Offering and Concurrent Private Placement

    RenovaCare, Inc., , developer of the SkinGun™ and CellMist™ System for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced that it has entered into definitive agreements with investors to purchase an aggregate of approximately 915,000 shares of common stock in a registered direct offering and common stock purchase warrants in a concurrent ...

  • Peer-Reviewed Publication Validates RenovaCare Approach to Rapidly-Processing Stem Cells for Burns and Wounds
    Business Wire10 months ago

    Peer-Reviewed Publication Validates RenovaCare Approach to Rapidly-Processing Stem Cells for Burns and Wounds

    RenovaCare, Inc., , has announced that its approach to isolating a patient’s own stem cells for subsequent spray onto burns and wounds has been validated by researchers in ‘Differentiation’, a leading peer-reviewed scientific publication.